| Name | Title | Contact Details |
|---|
Porter is an AI-driven Healthsphere that includes navigable content, a curated marketplace, coverage information, and supportive online health communities that deliver actionable insights to transform the care-at-home journey. Porter`s platform guides patients and caregivers to make informed, personalized health decisions based on their own speed, quality, and cost desires.
Johnson Regional Medical Center is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Clarksville, AR. To find more information about Johnson Regional Medical Center, please visit www.jrmc.com
HealthCare Ventures LLC is a Princeton, NJ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
The Cook County Health and Hospitals Systems mission is to deliver integrated health services with dignity and respect regardless of a patients ability to pay; foster partnerships with other health providers and communities to enhance the health of the public; and advocate for policies that promote the physical, mental and social well being of the people of Cook County. CCHHS is comprised of two hospitals, John H. Stroger, Jr. Hospital and Provident Hospital, a robust network of more than a dozen community health centers, the Ruth M. Rothstein CORE Center, the Cook County Department of Public Health, Cermak Health Services, which provides health care to individuals at the Cook County Jail and the Juvenile Temporary Detention Center, and CountyCare, a Medicaid managed care health plan. The system cares for more than 300,000 patients each year and its physicians are experts in their fields, committed to providing their patients with comprehensive, compassionate and cutting-edge care. Today, CCHHS is transforming the provision of health care in Cook County by promoting community-based primary and preventive care, growing an innovative, collaborative health plan and enhancing the patient experience.
Imagin Medical is developing imaging solutions for the early detection of cancer through the use of endoscopes. The Company believes it will radically improve the way physicians detect cancer. Imagin`s initial target market is bladder cancer, a major cancer worldwide, the sixth most prevalent in the U.S., and the most costly cancer to treat due to a greater than 50% recurrence rate. Developed at the Lawrence Livermore National Laboratory, this advanced, ultrasensitive imaging technology is based upon improved optical designs and advanced light sensors.